Clinical Trials Directory

Trials / Completed

CompletedNCT02621320

Vitamin D Supplementation in Wheelchair Indoor Athletes

Effect of Vitamin D3 Supplementation on Exercise Performance in Wheelchair Athletes.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Swiss Paraplegic Research, Nottwil · Network
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

There is a high prevalence of vitamin D deficiency in Switzerland. In indoor-athletes as well as wheelchair users, vitamin D deficiency occurs even more often. It is well established that vitamin D deficiency has a negative effect on health. However, vitamin D supplementation in individuals with a vitamin D deficiency has a positive effect on muscle performance. In recently published studies with able-bodied subjects, it has been shown that a normal vitamin D level (\>75nmol/L) can only be achieved with a high-dose supplementation of vitamin D. The aim of this study is to examine the effect of vitamin D supplementation on exercise performance in wheelchair athletes with vitamin D deficiency . All participants with a vitamin D deficiency are assigned to the intervention group and treated with 6000 IU of vitamin D3 daily over a period of 12 weeks. All participants who have a normal vitamin D level will receive placebo treatment (control group). The physical performance is measured three times at baseline, after six weeks and 12 weeks. The measurements include a Wingate and a dynamometer test.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin DVitamin D3 (Vi-De 3®. WILD) 6000IU daily over a period of 12 weeks.
DIETARY_SUPPLEMENTPlaceboalcohol-based solution 1.3ml daily over a period of 12 weeks.

Timeline

Start date
2015-11-01
Primary completion
2016-07-01
Completion
2016-08-01
First posted
2015-12-03
Last updated
2016-11-22

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02621320. Inclusion in this directory is not an endorsement.